Moreover, its overexpression is strongly correlated with the immunosuppressive tumor microenvironment, metastatic behavior, and poor patient outcomes, suggesting that TIMP1 could serve as a promising prognostic biomarker for CRC and CRLM. Here, TIMP1 is linked to colorectal carcinoma.